Atelectasis and survival after bronchoscopic lung volume reduction for COPD

European Respiratory Journal

Volumn 37, Issue 6, 2011, Pages 1346-1351

  Hopkinson, N S ^a   Kemp, S V ^a   Toma, T P ^a   Hansell, D M ^a   Geddes, D M ^a   Shah, P L ^a   Polkey, M I ^a  

^a ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Emphysema; Interventional bronchoscopy; Mortality

Indexed keywords

ARTICLE; ATELECTASIS; BICYCLE ERGOMETRY; BODY MASS; BRONCHOSCOPY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE EXACERBATION; EXERCISE; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FUNCTION; LUNG RESECTION; MALE; MORTALITY; PNEUMOTHORAX; PREDICTION; PRIORITY JOURNAL; QUALITY OF LIFE; SURVIVAL RATE; THORAX DRAINAGE; THORAX RADIOGRAPHY; WALKING;

BODY MASS INDEX; BRONCHOSCOPY; EXERCISE TEST; FEMALE; HUMANS; LUNG; MALE; MIDDLE AGED; PHYSICAL ENDURANCE; PNEUMONECTOMY; PULMONARY ATELECTASIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY EMPHYSEMA; QUALITY OF LIFE; TREATMENT OUTCOME;

EID: 79958007877     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00100110     Document Type: Article

References (33)

1. Geddes D, Davies M, Koyama H, et al. Effect of lung-volume-reduction surgery in patients with severe emphysema. N Engl J Med 2000; 343: 239-245. (Pubitemid 30490391)
2. National Emphysema Treatment Trial Research Group. A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med 2003; 348: 2059-2073.
3. Ferguson GT, Fernandez E, Zamora MR, et al. Improved exercise performance following lung volume reduction surgery for emphysema. Am J Respir Crit Care Med 1998; 157: 1195-1203.
4. Sciurba FC, Ernst A, Herth FJF, et al. A randomized study of endobronchial valves for advanced emphysema. New Engl J Med 2010; 363: 1233-1244.
5. Moore AJ, Cetti E, Haj-Yahia S, et al. Unilateral extrapulmonary airway bypass in advanced emphysema. Ann Thorac Surg 2010; 89: 899-906.
6. Choong CK, Cardoso PF, Sybrecht GW, et al. Airway bypass treatment of severe homogeneous emphysema: taking advantage of collateral ventilation. Thorac Surg Clin 2009; 19: 239-245.
7. Snell GI, Holsworth L, Borrill ZL, et al. The potential for bronchoscopic lung volume reduction using bronchial prostheses: a pilot study. Chest 2003; 124: 1073-1080. (Pubitemid 37123332)
8. Yim AP, Hwong TM, Lee TW, et al. Early results of endoscopic lung volume reduction for emphysema. J Thorac Cardiovasc Surg 2004; 127: 1564-1573. (Pubitemid 38725432)
9. Wan IY, Toma TP, Geddes DM, et al. Bronchoscopic lung volume reduction for end-stage emphysema: report on the first 98 patients. Chest 2006; 129: 518-526.
10. Venuta F, de Giacomo T, Rendina EA, et al. Bronchoscopic lung-volume reduction with one-way valves in patients with heterogenous emphysema. Ann Thorac Surg 2005; 79: 411-416. (Pubitemid 40186528)
11. de Oliveira HG, Macedo-Neto AV, John AB, et al. Transbronchoscopic pulmonary emphysema treatment: 1-month to 24-month endoscopic follow-up. Chest 2006; 130: 190-199. (Pubitemid 44116859)
12. Wood DE, McKenna RJ Jr, Yusen RD, et al. A multicenter trial of an intrabronchial valve for treatment of severe emphysema. J Thorac Cardiovasc Surg 2007; 133: 65-73.
13. Galluccio G, Lucantoni G. Bronchoscopic lung volume reduction for pulmonary emphysema: preliminary experience with a new NOVATECH® endobronchial silicone one-way valve. Interact CardioVasc Thorac Surg 2010; 11: 213-215.
14. Hopkinson NS, Toma TP, Hansell DM, et al. Effect of bronchoscopic lung volume reduction on dynamic hyperinflation and exercise in emphysema. Am J Respir Crit Care Med 2005; 171: 453-460. (Pubitemid 40444245)
15. Toma TP, Hopkinson NS, Hillier J, et al. Bronchoscopic volume reduction with valve implants in patients with severe emphysema. Lancet 2003; 361: 931-933. (Pubitemid 36332110)
16. Springmeyer SC, Bolliger CT, Waddell TK, et al. Treatment of heterogeneous emphysema using the spiration IBV valves. Thorac Surg Clin 2009; 19: 247-253.
17. Ingenito EP, Berger RL, Henderson AC, et al. Bronchoscopic lung volume reduction using tissue engineering principles. Am J Respir Crit Care Med 2003; 167: 771-778. (Pubitemid 36801757)
18. Pauwels RA, Buist AS, Calverley PM, et al. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. NHLBI/WHO global initiative for chronic obstructive lung disease (GOLD) workshop summary. Am J Respir Crit Care Med 2001; 163: 1256-1276. (Pubitemid 32378468)
19. Toma TP, Polkey MI, Goldstraw PG, et al. Methodological aspects of bronchoscopic lung volume reduction with a proprietary system. Respiration 2003; 70: 658-664. (Pubitemid 38142323)
20. 1-antitrypsin deficiency influences lung function impairment. Am J Respir Crit Care Med 2004; 170: 1172-1178.
21. Puhan MA, Garcia-Aymerich J, Frey M, et al. Expansion of the prognostic assessment of patients with chronic obstructive pulmonary disease: the updated BODE index and the ADO index. Lancet 2009; 374: 704-711.
22. Martinez FJ, Foster G, Curtis JL, et al. Predictors of mortality in patients with emphysema and severe airflow obstruction. Am J Respir Crit Care Med 2006; 173: 1326-1334. (Pubitemid 43900706)
23. Celli BR, Cote CG, Marin JM, et al. The body-mass index, airflow obstruction, dyspnoea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004; 350: 1005-1012. (Pubitemid 38269277)
24. Moore AJ, Soler RS, Cetti EJ, et al. Sniff nasal inspiratory pressure versus IC/TLC ratio as predictors of mortality in COPD. Respir Med 2010; 104: 1319-1325.
25. Hamnegard CH, Polkey MI, Thylen A, et al. Effect of lung volume reduction surgery for emphysema on diaphragm function. Respir Physiol Neurobiol 2006; 150: 182-190. (Pubitemid 43227457)
26. Takayama T, Shindoh C, Kurokawa Y, et al. Effects of lung volume reduction surgery for emphysema on oxygen cost of breathing. Chest 2003; 123: 1847-1852. (Pubitemid 36706703)
27. Casanova C, Cote C, de Torres JP, et al. Inspiratory-to-total lung capacity ratio predicts mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005; 171: 591-597. (Pubitemid 40365414)
28. Garcia-Rio F, Lores V, Mediano O, et al. Daily physical activity in patients with chronic obstructive pulmonary disease is mainly associated with dynamic hyperinflation. Am J Respir Crit Care Med 2009; 180: 506-512.
29. Hopkinson NS, Polkey MI. Does physical inactivity cause chronic obstructive pulmonary disease? Clin Sci (Lond) 2010; 118: 565-572.
30. Watz H, Waschki B, Boehme C, et al. Extrapulmonary effects of chronic obstructive pulmonary disease on physical activity: a cross-sectional study. Am J Respir Crit Care Med 2008; 177: 743-751. (Pubitemid 351490561)
31. Mineo D, Ambrogi V, Cufari ME, et al. Variations of inflammatory mediators and a1-antitrypsin levels after lung volume reduction surgery for emphysema. Am J Respir Crit Care Med 2010; 181: 806-814.
32. Heindl S, Lehnert M, Criee C-P, et al. marked sympathetic activation in patients with chronic respiratory failure. Am J Respir Crit Care Med 2001; 164: 597-601. (Pubitemid 32801663)
33. Barr RG, Bluemke DA, Ahmed FS, et al. Percent emphysema, airflow obstruction, and impaired left ventricular filling. N Engl J Med 2010; 362: 217-227.